New patent for Mayne Pharma drug BIJUVA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for BIJUVA
Annual Drug Patent Expirations for BIJUVA

Bijuva is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting this drug.

BIJUVA drug price trends.

Drug patent litigation for BIJUVA.

This drug has one hundred and sixty-three patent family members in twenty-one countries.

The generic ingredient in BIJUVA is estradiol; progesterone. Two suppliers are listed for this compound. Additional details are available on the estradiol; progesterone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top